Anna Coenen-Stass

Olaparib and durvalumab in patients with germline BRCA-mutated metastatic breast cancer (MEDIOLA): an open-label, multicentre, phase 1/2, basket study

Susan M. Domchek, Sophie Postel‐Vinay, Seock‐Ah Im et al. · The Lancet Oncology · 2020 · 459 citations

Medicine, Oncology, Pharmacology +15

TRIM Protein-Mediated Regulation of Inflammatory and Innate Immune Signaling and Its Association with Antiretroviral Activity

Pradeep D. Uchil, Angelika Hinz, Steven J. Siegel et al. · Journal of Virology · 2012 · 218 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Circulating miR-181 is a prognostic biomarker for amyotrophic lateral sclerosis

Iddo Magen, Nancy‐Sarah Yacovzada, Eran Yanowski et al. · Nature Neuroscience · 2021 · 137 citations

Life Sciences, Neurology, Neuroscience +14

Assessment of RT-qPCR Normalization Strategies for Accurate Quantification of Extracellular microRNAs in Murine Serum

Thomas C. Roberts, Anna Coenen-Stass, Matthew J. A. Wood · PLoS ONE · 2014 · 132 citations · Full text

Medicine, Biomedical Sciences, Molecular Biology +17

Longitudinal immune characterization of syngeneic tumor models to enable model selection for immune oncology drug discovery

Molly A. Taylor, Adina Hughes, Josephine Walton et al. · Journal for ImmunoTherapy of Cancer · 2019 · 102 citations · Full text

Life Sciences, Immunology, Oncology +17